Publicaciones (24) Publicaciones de Manuel Sáenz de Viteri Vázquez

2024

  1. Macular Neovascularization Type Influence on Anti-VEGF Intravitreal Therapy Outcomes in Age-Related Macular Degeneration

    Ophthalmology Retina, Vol. 8, Núm. 4, pp. 350-359

  2. Treat-and-Extend Versus Pro re nata Regimens of Ranibizumab and Aflibercept in Neovascular Age-Related Macular Degeneration: A Comparative Study from Routine Clinical Practice

    Ophthalmology and Therapy, Vol. 13, Núm. 9, pp. 2343-2355

2022

  1. A Cross-Sectional Observational Study of the Relationship between Outdoor Exposure and Myopia in University Students, Measured by Conjunctival Ultraviolet Autofluorescence (CUVAF)

    Journal of Clinical Medicine, Vol. 11, Núm. 15

  2. Creation of a neovascular age-related macular degeneration national database using a web-based platform: Fight Retinal Blindness Spain. Report 1: Visual outcomes

    Clinical and Experimental Ophthalmology, Vol. 50, Núm. 3, pp. 312-324

  3. Incidence, Risk Factors, and Outcomes of Rhegmatogenous Retinal Detachment after Intravitreal Injections of Anti-VEGF for Retinal Diseases: Data from the Fight Retinal Blindness! Registry

    Ophthalmology Retina, Vol. 6, Núm. 11, pp. 1044-1053

  4. Respuesta al comentario «El menosprecio de lo próximo», relativo al editorial «Inteligencia artificial y Oftalmología: Estado actual»

    Archivos de la Sociedad Española de Oftalmologia, Vol. 97, Núm. 7, pp. 418-419

  5. The role of retinal fluid location in atrophy and fibrosis evolution of patients with neovascular age-related macular degeneration long-term treated in real world

    Acta ophthalmologica, Vol. 100, Núm. 2, pp. e521-e531

2021

  1. Anti-inflammatory and anti-oxidative synergistic effect of vitamin d and nutritional complex on retinal pigment epithelial and endothelial cell lines against age-related macular degeneration

    Nutrients, Vol. 13, Núm. 5

  2. Evaluation of macular retinal vessels and histological changes in two cases of covid-19

    Biomedicines, Vol. 9, Núm. 11

  3. Inteligencia artificial y oftalmología: estado actual

    Archivos de la Sociedad Española de Oftalmologia, Vol. 96, Núm. 8, pp. 399-400

  4. Persistent retinal microvascular impairment in covid-19 bilateral pneumonia at 6-months follow-up assessed by optical coherence tomography angiography

    Biomedicines, Vol. 9, Núm. 5

  5. Role of intraretinal and subretinal fluid on clinical and anatomical outcomes in patients with neovascular age-related macular degeneration treated with bimonthly, treat-and-extend and as-needed ranibizumab in the In-Eye study

    Acta ophthalmologica, Vol. 99, Núm. 8, pp. 861-870

2020

  1. A higher proportion of eicosapentaenoic acid (EPA) when combined with docosahexaenoic acid (DHA) in omega-3 dietary supplements provides higher antioxidant effects in human retinal cells

    Antioxidants, Vol. 9, Núm. 9, pp. 1-16

2019

  1. Bilateral cystoid macular edema in a patient with chronic lymphocytic leukemia treated with ibrutinib

    Leukemia and Lymphoma

2018

  1. Comparison of cumulative dissipated energy delivered by active-fluidic pressure control phacoemulsification system versus gravity-fluidics

    International Ophthalmology, Vol. 38, Núm. 5, pp. 1907-1913

  2. Novel association of high C-reactive protein levels and A69S at risk alleles in wet age-related macular degeneration women

    Frontiers in Immunology, Vol. 9, Núm. AUG

2017

  1. Evaluation of VEGF gene polymorphisms and proliferative diabetic retinopathy in mexican population

    International Journal of Ophthalmology, Vol. 10, Núm. 1, pp. 135-139

2016

  1. Optical Coherence Tomography Assessment before and after Vitamin Supplementation in a Patient with Vitamin A Deficiency

    Medicine (United States), Vol. 95, Núm. 6

  2. Patient considerations in cataract surgery - The role of combined therapy using phenylephrine and ketorolac

    Patient Preference and Adherence, Vol. 10, pp. 1795-1801

  3. Single- and repeated-dose toxicity study of bevacizumab, ranibizumab, and aflibercept in ARPE-19 cells under normal and oxidative stress conditions

    Biochemical Pharmacology, Vol. 103, pp. 129-139